Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
PuraPharm Corp. Ltd. ( (HK:1498) ) just unveiled an update.
PuraPharm Corporation Limited has announced its upcoming Annual General Meeting scheduled for May 27, 2025, in Hong Kong. Key agenda items include the adoption of the 2024 financial statements, re-election of directors, re-appointment of the auditor, and a proposal for a share buyback mandate. These resolutions aim to strengthen corporate governance and potentially enhance shareholder value.
More about PuraPharm Corp. Ltd.
PuraPharm Corporation Limited operates in the pharmaceutical industry, focusing on the development and production of Chinese medicine products. The company is incorporated in the Cayman Islands and is listed on the Hong Kong Stock Exchange.
YTD Price Performance: -11.82%
Average Trading Volume: 127,300
Technical Sentiment Signal: Buy
Current Market Cap: HK$191.5M
See more data about 1498 stock on TipRanks’ Stock Analysis page.